These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16627363)

  • 61. Vasoconstriction elicited by addition of plasma to vasoinactive tissue extracts.
    MYLON E; HELLER JH
    Proc Soc Exp Biol Med; 1947 Nov; 66(2):319-21. PubMed ID: 18921745
    [No Abstract]   [Full Text] [Related]  

  • 62. Abstracts of the 4th International Congress on Prediabetes and the Metabolic Syndrome, 6-9 April 2011, Madrid, Spain.
    J Diabetes; 2011 Apr; 3 Suppl 1():1-300. PubMed ID: 21401904
    [No Abstract]   [Full Text] [Related]  

  • 63. [Investigation of the coronary vessels in dogs with the aid of motion picture; preliminary communication].
    ANDREEV SV; TROFIMOVA ZG; BARSUKOVA AI
    Biull Eksp Biol Med; 1955 Mar; 39(3):75-9. PubMed ID: 14378276
    [No Abstract]   [Full Text] [Related]  

  • 64. A Gray Zone Population: Prediabetes-It Is Not as Easy as Its Look.
    Ozcan Cetin EH; Cetin MS; Diker E
    Angiology; 2019 Feb; 70(2):181. PubMed ID: 30033743
    [No Abstract]   [Full Text] [Related]  

  • 65. [The role of the coronary vasomotor nerves; personal data].
    ARNULF G
    Presse Med (1893); 1958 Dec; 66(90):2005-8. PubMed ID: 13623724
    [No Abstract]   [Full Text] [Related]  

  • 66. [Experimental data on coronary vasomotor nerves].
    ARNULF G
    Arch Mal Coeur Vaiss; 1959 Feb; 52(2):149-66. PubMed ID: 13638027
    [No Abstract]   [Full Text] [Related]  

  • 67. Endothelial cell dysfunction in cardiac disease: driver or consequence?
    Allbritton-King JD; García-Cardeña G
    Front Cell Dev Biol; 2023; 11():1278166. PubMed ID: 37965580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Experimental animal models of coronary microvascular dysfunction.
    Sorop O; van de Wouw J; Chandler S; Ohanyan V; Tune JD; Chilian WM; Merkus D; Bender SB; Duncker DJ
    Cardiovasc Res; 2020 Mar; 116(4):756-770. PubMed ID: 31926020
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.
    Brown SM; Meuth AI; Davis JW; Rector RS; Bender SB
    Pharmacol Res; 2018 Aug; 134():100-108. PubMed ID: 29870805
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.
    Labazi H; Trask AJ
    Pharmacol Res; 2017 Sep; 123():114-121. PubMed ID: 28700893
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
    Dincer UD
    Diabetes Metab Syndr Obes; 2012; 5():89-99. PubMed ID: 22563249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of voltage-dependent K⁺ channels to metabolic control of coronary blood flow.
    Berwick ZC; Dick GM; Moberly SP; Kohr MC; Sturek M; Tune JD
    J Mol Cell Cardiol; 2012 Apr; 52(4):912-9. PubMed ID: 21771599
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heart of the matter: coronary dysfunction in metabolic syndrome.
    Berwick ZC; Dick GM; Tune JD
    J Mol Cell Cardiol; 2012 Apr; 52(4):848-56. PubMed ID: 21767548
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity.
    Bender SB; Newcomer SC; Harold Laughlin M
    Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1434-41. PubMed ID: 21317309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation.
    Borbouse L; Dick GM; Payne GA; Berwick ZC; Neeb ZP; Alloosh M; Bratz IN; Sturek M; Tune JD
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1182-9. PubMed ID: 20118408
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Contribution of BK(Ca) channels to local metabolic coronary vasodilation: Effects of metabolic syndrome.
    Borbouse L; Dick GM; Payne GA; Payne BD; Svendsen MC; Neeb ZP; Alloosh M; Bratz IN; Sturek M; Tune JD
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H966-73. PubMed ID: 20044440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase.
    Payne GA; Borbouse L; Bratz IN; Roell WC; Bohlen HG; Dick GM; Tune JD
    Microcirculation; 2008 Jul; 15(5):417-26. PubMed ID: 18574744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome.
    Knudson JD; Rogers PA; Dincer UD; Bratz IN; Araiza AG; Dick GM; Tune JD
    Microcirculation; 2006; 13(3):209-18. PubMed ID: 16627363
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome.
    Dincer UD; Araiza AG; Knudson JD; Molina PE; Tune JD
    Microcirculation; 2006; 13(7):587-95. PubMed ID: 16990217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis.
    Sorop O; Merkus D; de Beer VJ; Houweling B; Pistea A; McFalls EO; Boomsma F; van Beusekom HM; van der Giessen WJ; VanBavel E; Duncker DJ
    Circ Res; 2008 Apr; 102(7):795-803. PubMed ID: 18292598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.